SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-111126
Filing Date
2020-10-01
Accepted
2020-10-01 16:57:42
Documents
16
Period of Report
2020-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032216-1_8k.htm   iXBRL 8-K 49426
2 EXHIBIT 2.1 tm2032216d1_ex2-1.htm EX-2.1 580236
3 EXHIBIT 99.1 tm2032216d1_ex99-1.htm EX-99.1 72954
4 EXHIBIT 99.2 tm2032216d1_ex99-2.htm EX-99.2 21810
8 GRAPHIC tm2032216-1_8kimg01.jpg GRAPHIC 6211
  Complete submission text file 0001104659-20-111126.txt   1071791

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA amag-20201001.xsd EX-101.SCH 2762
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE amag-20201001_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amag-20201001_pre.xml EX-101.PRE 22714
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2032216-1_8k_htm.xml XML 3502
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 201216863
SIC: 2834 Pharmaceutical Preparations